Dr. Kevin Terrence Palka, MD

Dr. Palka practices at SSM Health Good Samaritan Hospital - Mt. Vernon in Mount Vernon, Illinois, part of SSM Health Care.

Dr. Palka's NPI, 1689721482, was assigned on January 4, 2007. Dr. Palka graduated from University of Texas Southwestern Medical School at Dallas in 2001. Dr. Palka holds Missouri license 2015008493.

Dr. Palka's primary practice is SSM Health Good Samaritan Hospital - Mt. Vernon, at 1 Good Samaritan Way, Mount Vernon, IL 62864 in Jefferson County. The practice phone is (618) 899-2201.

Dr. Palka's primary practice is SSM Health Good Samaritan Hospital - Mt. Vernon in Mount Vernon, Illinois, part of SSM Health Care. Dr. Palka is also affiliated with Phelps Health Hospital. The medical group on file is SSM Health Medical Group. Dmand AI also links Dr. Palka to 4 more hospitals, 5 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Palka practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Palka's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Palka's licenses on file in 2 states: Missouri and Illinois.

CMS data shows 431 Medicare services from Dr. Palka across 7 procedure codes in 2024, for 159 Medicare patients. Medicare paid $36,437 for them.

CMS counts 159 Medicare patients who saw Dr. Palka in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Palka's median patient age at 73, with 50% women.

In 2024, Dr. Palka wrote 704 Medicare Part D claims for 106 patients. 84% of them were for generic drugs. CMS names the drug for 594 of them, across 24 drugs with 11 or more claims each, at $1,448,124 in total drug cost. In 2023, CMS named 462 claims across 20 drugs.

Dr. Palka accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Palka, published from 2019 to 2021. 2021 was the busiest year, with 3. The most frequent topics are Cetuximab, Antineoplastic Combined Chemotherapy Protocols and Albumins. Dr. Palka has published most often in Oral Oncol. Dr. Palka's most frequent co-authors are Peter John Oppelt, MD, Mackenzie D. Daly, MD and Hiram Alberto Gay, MD.

Dmand AI links Dr. Palka to 10 clinical trials, 8 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell and Carcinoma, Bronchogenic. Washington University School of Medicine sponsors the most, 10.

CMS Open Payments shows 421 general payments to Dr. Palka from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 76% of the total. Merck Sharp & Dohme Corporation paid the most, $113,379.

Dr. Palka graduated from University of Texas Southwestern Medical School at Dallas in 2001.